Delivery Order SPE2DE21D0005-SPE2D625F003Y
Award Date
10/22/24
Potential Completion Date
10/25/24
Potential Value
$3.7K
Federal Agency
Medical Supply Chain
Awardee
Organogenesis Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,719.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for the medical product APLIGRAF, a skin substitute. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million Indefinite Delivery Contract with the Department of Veterans Affairs (VA) for surgical implants, a $30 million...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products. The contract is a delivery order for the advanced wound care product APLIGRAF. Organogenesis has multiple Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, including a $25 million single-award IDC with the VA for surgical implants, a $30 million Federal...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,479.90 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, to provide APLIGRAF, a specialized skin substitute and wound matrix product. The contract has a period of performance through November 25, 2024 and utilizes a Fixed Price with Economic Price Adjustment pricing structure. Organogenesis is a for-profit manufacturer that has been awarded numerous federal contracts to supply a range...
This federal contract award, valued at $2,479.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The award is a delivery order contract for the APLIGRAF product, which is a specialized skin substitute and wound matrix used in medical treatments. Organogenesis has a robust presence in government medical procurement,...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract is a delivery order for the company's APLIGRAF product, a skin substitute used in advanced wound care. The award is part of a larger $183.15 million multiple-award Indefinite Delivery Contract (IDC) the DLA awarded to Organogenesis and other suppliers for medical and surgical supplies under the...
This federal contract award to Organogenesis Inc., a regenerative medicine company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,239.95 fixed-price delivery order is for the supply of APLIGRAF, an advanced wound care product, to support military medical needs. The contract has a ceiling value of $1,239.95 and runs through December 17, 2024. While the award does not utilize a set-aside designation, Organogenesis has been the recipient of prior contracts through...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,239.95 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, for the supply of APLIGRAF, a specialized wound care product. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of December 27, 2024. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million single-award Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The $2,479.90 fixed-price with economic price adjustment delivery order contract is for the supply of the advanced wound care product APLIGRAF. Organogenesis is the prime contractor, and there is no set-aside designation for this award. The company has previously received federal contracts through small business programs and...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for APLIGRAF, a skin substitute product. The contract has no set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare...
This is a $3,719.85 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The order is for the company's APLIGRAF advanced wound care product. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs (VA) for next-generation surgical...